Myovant Sciences: Q3 Earnings Insights

Myovant Sciences MYOV reported its Q3 earnings results on Wednesday, January 26, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Myovant Sciences missed estimated earnings by 13.33%, reporting an EPS of $-0.68 versus an estimate of $-0.6, which surprised analysts.

Revenue was up $53.06 million from the same period last year.

Last quarter the company beat on EPS by $0.15, which was followed by a 1.31% drop in the share price the next day.

Here's a look at Myovant Sciences's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	-0.38	-0.33	-0.99	-0.85
EPS Actual	-0.23	-0.67	-0.89	-0.82
Revenue Estimate	71.40M	57.05M	24.63M	2.17M
Revenue Actual	77.90M	41.06M	24.61M	1.38M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.